# OnCo record zev-wainberg (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/zev-wainberg/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "zev-wainberg" ;
  schema:name "Zev A. Wainberg"@en ;
  schema:description "Led NAPOLI 3, the trial that made NALIRIFOX a first-line option for metastatic pancreatic cancer."@en ;
  schema:url <https://onco.cc/people/zev-wainberg/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Wainberg%20ZA%5BAuthor%5D%20pancreatic%20NAPOLI> ;
  onco:tag "pancreatic", "gastric", "trialist" ;
  schema:jobTitle "Professor of Medicine and Co-Director, GI Oncology Program, UCLA Jonsson Comprehensive Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/>, <https://onco.cc/targets/fgfr2/> ;
  onco:institutions <https://onco.cc/institutions/ucla-jonsson/> ;
  onco:trials <https://onco.cc/trials/napoli-3/>, <https://onco.cc/trials/fortitude-101/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-napoli-3-lancet-2023/> ;
  schema:affiliation <https://onco.cc/institutions/ucla-jonsson/> .